SELSEHCC

SCIF 2013

SICKLE CELL IN FOCUS 2013

SCiF 2013 group photo
Sickle Cell in Focus (SCiF), 6 - 8 June 2013, King's College London, Denmark Hill campus (EHA-CME accredited: 15 points)

Once again, we had an overwhelmingly fantastic response to Sickle Cell in Focus this year, our 7th year of holding this event. The feedback has been excellent and we thank our speakers and delegates for contributing to SCiF’s success.

 

PROGRAMME

Old view King's College Hospital from Denmark Hill

THURSDAY 6 JUNE 2013

 SESSION 1  Sickle cell disease in adults

Sickle cell disease: a global health problem Sir David Weatherall, Weatherall Institute of Molecular Medicine, UK

Health maintenance in adults with sickle cell disease: a UK perspectiveJo Howard, Guy’s & St. Thomas’ NHS Foundation Trust

SESSION 2  Evolving Concepts and Emerging Therapies

Fetal haemoglobin: genetics to molecular mechanisms to targeted therapySwee Lay Thein, King’s College London / King’s College Hospital NHS Foundation Trust, UK

Biomarkers in sickle cell diseaseDavid Rees, King’s College London / King’s College Hospital NHS Foundation Trust, UK

Update on clinical trialsCarolyn Hoppe, Children’s Hospital Oakland, USA

Globin gene transfer for the treatment of the thalassemias and hemoglobinopathiesMichel Sadelain, Sloan-Kettering Institute, USA

SESSION 3  Mini-Symposium: Sickle Hepatopathy

Liver imaging: how useful is it? – Pauline Kane, King’s College Hospital NHS Foundation Trust, UK

Liver pathology – Alberto Quaglia, King’s College Hospital NHS Foundation Trust, UK

Liver complicationsAbid Suddle, King’s College Hospital NHS Foundation Trust, UK

SESSION 4  Debate: Is it justified to perform bone marrow transplant in sickle cell anaemia using unrelated and/or partially mismatched donors?

YesJohn Tisdale, National Institute of Health, USA

No – Miguel Abboud, American University of Beirut Medical Center, Lebanon

Day one close and network drinks (James Black Centre foyer)

FRIDAY 7 JUNE 2013

SESSION 1  Complications in adults with sickle cell disease

Avascular necrosisMarcus Bankes, Guy’s & St. Thomas’ NHS Foundation Trust, UK

Leg ulceration associated with sickle cell diseaseRichard Bull, Homerton University Hospital / Barts and the London,UK

Ophthalmologic complicationsSobha Sivaprasad, King’s College Hospital NHS Foundation Trust, UK

SESSION 2  Impact of New Technology in Sickle Cell Disease

Reproductive options:  pre-implantation genetic diagnosisTarek El-Touhky, Guy’s & St. Thomas’ NHS Foundation Trust, UK

Current and future trends in prenatal diagnosis in sickle cell disease – Barnaby Clark, King’s College Hospital NHS Foundation Trust, UK

Personalised medicine: a reality for sickle cell disease?Martin Steinberg, Boston University School of Medicine, USA

SESSION 3  Complications in adults with sickle cell disease

The many facets of sickle cell priapismNick Watkin, St. George’s Hospital, UK

Renal complicationsClaire Sharpe, King’s College London / King’s College Hospital NHS Foundation Trust, UK

Free session (delegate case presentations)

SESSION 4  Mini-Symposium: Vascular Pathobiology

Vascular pathology in sickle cell diseasePaul Frenette, Albert Einstein College of Medicine, USA

Modelling of microvascular occlusion using microfluidic technologyWilbur Lam, Emory University School of Medicine, USA

Pulmonary hypertensionGerald Simonneau, Hôpital Kremlin Bicêtre, France

Cerebrovascular disease in adults with sickle cell diseaseElliott Vichinsky, Children’s Hospital Oakland, USA

Day two close

SATURDAY 8 JUNE 2013

SESSION 1

The many pathophysiologies of sickle cell disease: six blind men and the elephant – Abdullah Kutlar, Medical College Georgia, USA

Blood transfusion and alloimmunisationMarilyn Telen, Duke University Medical Center

Free session (delegate case presentations)

SESSION 2           

Debate: Blood Transfusion Therapy in Sickle Cell Disease – Should We Be Doing More?

Yes – John Porter, University College London Hospitals, UK

NoGraham R. Serjeant, Sickle Cell Trust, Jamaica

CONFERENCE CLOSE

Testimonials

Here is what some of this year’s attendees had to say:

“This was my first time at such a conference. I found it very informative and it raised questions about clinical treatment and practice, which is essential to ensure clients receive the most appropriate care”

“An excellent conference from all aspects. The speakers were excellent and the contributions from everyone was good”

“A very educational conference. Thoroughly enjoyed the entire conference and look forward to next year”

“Very good meeting overall. Thank you”

“Excellent value for time/money. Excellent organisation. Thanks!”

“Excellent selection of topics/speakers”

“Great meeting!”

“Very informative, good speakers, good balance of science and clinical presentations”

“This has been the best conference I’ve attended. Each speaker gave fantastic presentations. I think timing and structure was perfect. Please continue the fantastic work!”

“Keep up the good organisation of the programme. There were numerous opportunities to meet people and expand my knowledge”

Scroll to Top